Titomic Limited
Titomic Limited (TITMF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Titomic Limited (TITMF), featuring income statements, balance sheets, and cash flow data.
Titomic Limited (TITMF) Income Statement & Financial Overview
View the income breakdown for Titomic Limited TITMF across both annual and quarterly reports.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $3.95M | $3.49M | $2.31M | $1.17M |
| Cost of Revenue | $3.21M | $2.30M | $2.73M | $5.29M |
| Gross Profit | $736176.00 | $1.19M | -$422084.00 | -$4.13M |
| Gross Profit Ratio | $0.19 | $0.34 | -$0.18 | -$3.53 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $7.16M | $6.50M | $7.08M | $2.39M |
| Operating Expenses | $7.16M | $6.50M | $7.08M | $2.39M |
| Total Costs & Expenses | $10.38M | $8.80M | $9.81M | $7.68M |
| Interest Income | $0.00 | $14597.00 | $191944.00 | $466198.00 |
| Interest Expense | $0.00 | $117287.00 | $0.00 | $466198.00 |
| Depreciation & Amortization | $71023.00 | $23054.00 | $98069.00 | $725989.00 |
| EBITDA | -$6.48M | -$5.38M | -$6.56M | -$6.90M |
| EBITDA Ratio | -$1.64 | -$1.54 | -$2.84 | -$4.96 |
| Operating Income | -$6.43M | -$5.31M | -$7.50M | -$6.52M |
| Operating Income Ratio | -$1.63 | -$1.52 | -$3.25 | -$5.58 |
| Other Income/Expenses (Net) | -$238577.00 | -$506744.00 | $659818.00 | -$1.57M |
| Income Before Tax | -$6.67M | -$5.82M | -$6.85M | -$8.09M |
| Income Before Tax Ratio | -$1.69 | -$1.67 | -$2.97 | -$6.93 |
| Income Tax Expense | $94902.00 | $169868.00 | -$941136.00 | $1.00 |
| Net Income | -$6.57M | -$5.99M | -$5.90M | -$8.09M |
| Net Income Ratio | -$1.66 | -$1.72 | -$2.56 | -$6.93 |
| EPS | -$0.00 | -$0.007 | -$0.007 | -$0.03 |
| Diluted EPS | -$0.00 | -$0.007 | -$0.007 | -$0.03 |
| Weighted Avg Shares Outstanding | $109.52B | $111.22B | $106.96B | $232.18M |
| Weighted Avg Shares Outstanding (Diluted) | $109.52B | $111.21B | $106.96B | $232.18M |
Over the past four quarters, Titomic Limited demonstrated steady revenue growth, increasing from $1.17M in Q4 2023 to $3.95M in Q2 2025. Operating income reached -$6.43M in Q2 2025, maintaining a consistent -163% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$6.48M, reflecting operational efficiency. Net income dropped to -$6.57M, with EPS at -$0.00. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan